Jones Financial Companies’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.8M Sell
407,824
-274,695
-40% -$8.72M ﹤0.01% 861
2026
Q1
$20.9M Buy
682,519
+678,210
+15,739% +$21.4M 0.01% 577
2025
Q4
$127K Sell
4,309
-5,151
-54% -$143K ﹤0.01% 2128
2025
Q3
$234K Sell
9,460
-3,253
-26% -$79.3K ﹤0.01% 1726
2025
Q2
$310K Buy
12,713
+639
+5% +$14.8K ﹤0.01% 1474
2025
Q1
$276K Buy
12,074
+3,039
+34% +$73.3K ﹤0.01% 1361
2024
Q4
$229K Buy
9,035
+2,446
+37% +$62K ﹤0.01% 1294
2024
Q3
$169K Buy
6,589
+3,086
+88% +$91.4K ﹤0.01% 1195
2024
Q2
$104K Buy
3,503
+3,464
+8,882% +$96.1K ﹤0.01% 1036
2024
Q1
$1.18K Buy
39
+31
+388% +$860 ﹤0.01% 1297
2023
Q4
$229 Buy
+8
New +$235 ﹤0.01% 1005

Other funds holding RTO

Jones Financial Companies's RTO Position: Q2 2026 in Review

Jones Financial Companies reduced its Rentokil (RTO) stake by 40% in Q2 2026, selling an estimated $8.72M and leaving 407,824 shares worth $11.8M. The position accounts for ﹤0.01% of the portfolio, ranked #861.

Jones Financial Companies first reported a position in RTO in Q4 2023 and has held it in 11 quarters since. The position peaked at $20.9M in Q1 2026. 284 funds tracked by Wall St. Rank hold RTO as of Q2 2026.

  • Jones Financial Companies held 407,824 shares of Rentokil worth $11.8M as of Q2 2026.
  • Jones Financial Companies sold 274,695 Rentokil shares in Q2 2026, an estimated $8.72M.
  • Rentokil made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #861 holding.
  • Jones Financial Companies first reported a position in Rentokil in Q4 2023 and has held it in 11 quarters since.
  • Jones Financial Companies's Rentokil position peaked at $20.9M in Q1 2026.
  • 284 funds tracked by Wall St. Rank held Rentokil as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.